RetinalGenix Technologies (RTGN) Accounts Payables (2020 - 2026)
RetinalGenix Technologies (RTGN) posted Accounts Payables of $1.2 million for Q1 2026, up 9.66% sequentially from $1.1 million in Q4 2025, and up 28.83% YoY from $923340.0 in Q1 2025.
RetinalGenix Technologies (RTGN) Accounts Payables (2020 - 2026) Analysis & Trends
RetinalGenix Technologies has reported Accounts Payables for 7 years, with the latest figure at $1.2 million in Q1 2026.
- Quarterly Accounts Payables rose 28.83% year-over-year to $1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 million (up 28.83% YoY) and the FY2025 annual result came in at $1.1 million, up 17.64% from the prior year.
- Accounts Payables grew to $1.2 million in Q1 2026 per RTGN's latest filing, from $1.1 million in the prior quarter.
- Over five years, Accounts Payables peaked at $1.2 million in Q1 2026 and troughed at $262467.0 in Q1 2022.
- A 5-year average of $773379.6 and a median of $862453.0 in 2024 frame the typical range for Accounts Payables.
- The sharpest annual moves came in 2023 and 2024: Accounts Payables jumped 141.62% in 2023, then gained 4.2% in 2024.
- Over 5 years, Accounts Payables stood at $475480.0 in 2022, then soared by 86.11% to $884920.0 in 2023, then rose by 4.2% to $922083.0 in 2024, then rose by 17.64% to $1.1 million in 2025, then rose by 9.66% to $1.2 million in 2026.
- According to Business Quant data, Accounts Payables over the past three periods registered $1.2 million, $1.1 million, and $1.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 4.79 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 1.66 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 2.64 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 1.23 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 210.50 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 3.23 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 2.42 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 344.10 Mn |
| 10 | RetinalGenix Technologies | 75.02 Mn | 75.02 Mn | - | 1.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.19 Mn |
| Dec 31, 2025 | 1.08 Mn |
| Sep 30, 2025 | 1.04 Mn |
| Jun 30, 2025 | 1.02 Mn |
| Mar 31, 2025 | 923,340.00 |
| Dec 31, 2024 | 922,083.00 |
| Sep 30, 2024 | 885,564.00 |
| Jun 30, 2024 | 862,453.00 |
| Mar 31, 2024 | 813,638.00 |
| Dec 31, 2023 | 884,920.00 |
| Sep 30, 2023 | 751,388.00 |
| Jun 30, 2023 | 697,073.00 |
| Mar 31, 2023 | 634,181.00 |
| Dec 31, 2022 | 475,480.00 |
| Sep 30, 2022 | 366,687.00 |
| Jun 30, 2022 | 339,579.00 |
| Mar 31, 2022 | 262,467.00 |
| Dec 31, 2021 | 251,282.00 |
| Sep 30, 2021 | 210,873.00 |
| Dec 31, 2020 | 141,431.00 |